Showing results (331-340 of 602) with videos related to

Sort By:
Pageof 61
British Journal of Haematology|May 1, 2018
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantationRajshekhar Chakraborty, Eli Muchtar, Shaji K Kumar, et al.
American Journal of Hematology|November 15, 2011
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosisMaria V Irazabal, Alfonso Eirin, Morie A Gertz, et al.
Hematology (Amsterdam, Netherlands)|December 12, 2024
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuriaDavid Dingli, Carlos De Castro Iii, Jamie Koprivnikar, et al.
Leukemia & Lymphoma|April 11, 2015
Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and bothLadan Zand, Samih H Nasr, Morie A Gertz, et al.
Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.
Blood Cancer Journal|April 5, 2023
Prognostic value of early bone marrow MRD status in CAR-T therapy for myelomaRadhika Bansal, Mizba Baksh, Jeremy T Larsen, et al.
Nature|March 25, 2021
Breast tumours maintain a reservoir of subclonal diversity during expansionDarlan C Minussi, Michael D Nicholson, Hanghui Ye, et al.
American Journal of Hematology|March 20, 2013
Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphomaTaxiarchis V Kourelis, Morie Gertz, Clive Zent, et al.
Mayo Clinic Proceedings|February 6, 2019
Prognostic Significance of Holter Monitor Findings in Patients With Light Chain AmyloidosisSurbhi Sidana, Nidhi Tandon, Peter A Brady, et al.
Kidney International Reports|May 2, 2022
Kidney Transplant Outcomes of Patients With Multiple MyelomaCihan Heybeli, Andrew J Bentall, Mariam Priya Alexander, et al.
Pageof 61